Merck says experimental Hepatitis C treatment shows 95% cure rate

Company remains on track to submit New Drug Application to FDA in first half of this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.